Genome-Wide Association of Multiple Complex Traits in Outbred Mice by Ultra Low-Coverage Sequencing
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Network-Based Analysis of the Cellular and Genetic Etiology of Disease
A network-based analysis of the cellular and genetic etiology of disease Alexander John Cornish Submitted in part-fulfilment of the requirements for the degree of Doctor of Philosophy of Imperial College London and the Diploma of Imperial College London Department of Life Sciences Imperial College London 2016 1 Declaration The contents of this thesis are my own work unless otherwise specified. The copyright of this thesis rests with the author and is made available under a Creative Commons Attribution Non-Commercial No Derivatives licence. Researchers are free to copy, distribute or transmit the thesis on the condition that they attribute it, that they do not use it for commercial purposes and that they do not alter, transform or build upon it. For any reuse or redistribution, researchers must make clear to others the licence terms of this work. Alexander John Cornish 2 Abstract Thousands of disease-associated loci have been identified in genome-wide association studies (GWAS). These loci can span multiple genes and identifying which, if any, of these genes are causal can be challenging. Multiple methods have been developed to identify causal genes, some of which use networks of physical interactions between proteins. The performance of many of these methods may however be limited by their failure to use data specific to the tissues and cell types that manifest each disease. Furthermore, many network-based approaches may be biased towards better-studied genes. In order to use data specific to a disease-manifesting cell type to identify disease- associated genes, it is first necessary to identify the disease-manifesting cell types. -
Connecting Differentially Expressed Genes, Mirnas, and Lncrnas
School of Sciences and Engineering Regulatory Networks in Non-Small Cell Lung Cancer: Connecting Differentially Expressed Genes, miRNAs, and lncRNAs A Thesis Submitted to the: The Biotechnology Graduate Program In partial fulfillment of the requirements for The degree of Master of Science in Biotechnology By: Jasmine Kamal Omran Bachelor of Science in Human Biology, University of California San Diego Under the supervision of Dr. Hassan Azzazy Professor, Department of Chemistry, The American University in Cairo December/2016 The American University in Cairo School of Science and Engineering Regulatory Networks in Non- Small Cell Lung Cancer: Connecting Differentially Expressed Genes, miRNAs, and lncRNAs A Thesis Submitted by: Jasmine Kamal Omran To the Biotechnology Graduate Program December 2016 In partial fulfillment of the requirements for the degree of Master of Science in Biotechnology Has been approved by: Thesis Committee Supervisor/Chair ________________________________________________ Affiliation_____________________________________________________________________ Thesis Committee Supervisor _____________________________________________________ Affiliation_____________________________________________________________________ Thesis Committee Reader/Examiner ________________________________________________ Affiliation_____________________________________________________________________ Thesis Committee Reader/Examiner ________________________________________________ Affiliation_____________________________________________________________________ -
Genetic and Regulatory Mechanism of Susceptibility to High-Hyperdiploid Acute Lymphoblastic Leukaemia at 10P21.2
ARTICLE Received 13 Jul 2016 | Accepted 17 Jan 2017 | Published 3 Mar 2017 | Updated 25 May 2018 DOI: 10.1038/ncomms14616 OPEN Genetic and regulatory mechanism of susceptibility to high-hyperdiploid acute lymphoblastic leukaemia at 10q21.2 James B. Studd1, Jayaram Vijayakrishnan1, Minjun Yang2, Gabriele Migliorini1, Kajsa Paulsson2 & Richard S. Houlston1,3 Despite high-hyperdiploid acute lymphoblastic leukaemia (HD-ALL) being the most common subgroup of paediatric ALL, its aetiology remains unknown. Genome-wide association studies have demonstrated association at 10q21.2. Here, we sought to determine how this region influences HD-ALL risk. We impute genotypes across the locus, finding the single nucleotide polymorphism rs7090445 highly associated with HD-ALL (P ¼ 1.54 Â 10 À 38), and residing in a predicted enhancer element. We show this region physically interacts with the transcription start site of ARID5B, that alleles of rs7090445 have differential enhancer activity and influence RUNX3 binding. RUNX3 knock-down reduces ARID5B expression and rs7090445 enhancer activity. Individuals carrying the rs7090445-C risk allele also have reduced ARID5B expression. Finally, the rs7090445-C risk allele is preferentially retained in HD-ALL blasts consistent with inherited genetic variation contributing to arrest of normal lymphocyte development, facilitating leukaemic clonal expansion. These data provide evidence for a biological mechanism underlying hereditary risk of HD-ALL at 10q21.2. 1 Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London SM2 5NG, UK. 2 Department of Laboratory Medicine, Division of Clinical Genetics, Lund University, BMC C13, Lund SE-221 84, Sweden. 3 Division of Molecular Pathology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London SM2 5NG, UK. -
Ectopic Protein Interactions Within BRD4–Chromatin Complexes Drive
Ectopic protein interactions within BRD4–chromatin PNAS PLUS complexes drive oncogenic megadomain formation in NUT midline carcinoma Artyom A. Alekseyenkoa,b,1, Erica M. Walshc,1, Barry M. Zeea,b, Tibor Pakozdid, Peter Hsic, Madeleine E. Lemieuxe, Paola Dal Cinc, Tan A. Incef,g,h,i, Peter V. Kharchenkod,j, Mitzi I. Kurodaa,b,2, and Christopher A. Frenchc,2 aDivision of Genetics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115; bDepartment of Genetics, Harvard Medical School, Boston, MA 02115; cDepartment of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115; dDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA 02115; eBioinfo, Plantagenet, ON, Canada K0B 1L0; fDepartment of Pathology, University of Miami Miller School of Medicine, Miami, FL 33136; gBraman Family Breast Cancer Institute, University of Miami Miller School of Medicine, Miami, FL 33136; hInterdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136; iSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136; and jHarvard Stem Cell Institute, Cambridge, MA 02138 Contributed by Mitzi I. Kuroda, April 6, 2017 (sent for review February 7, 2017; reviewed by Sharon Y. R. Dent and Jerry L. Workman) To investigate the mechanism that drives dramatic mistargeting of and, in the case of MYC, leads to differentiation in culture (2, 3). active chromatin in NUT midline carcinoma (NMC), we have Similarly, small-molecule BET inhibitors such as JQ1, which identified protein interactions unique to the BRD4–NUT fusion disengage BRD4–NUT from chromatin, diminish megadomain- oncoprotein compared with wild-type BRD4. -
Ectopic Protein Interactions Within BRD4–Chromatin Complexes Drive Oncogenic Megadomain Formation in NUT Midline Carcinoma
Ectopic protein interactions within BRD4–chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma Artyom A. Alekseyenkoa,b,1, Erica M. Walshc,1, Barry M. Zeea,b, Tibor Pakozdid, Peter Hsic, Madeleine E. Lemieuxe, Paola Dal Cinc, Tan A. Incef,g,h,i, Peter V. Kharchenkod,j, Mitzi I. Kurodaa,b,2, and Christopher A. Frenchc,2 aDivision of Genetics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115; bDepartment of Genetics, Harvard Medical School, Boston, MA 02115; cDepartment of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115; dDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA 02115; eBioinfo, Plantagenet, ON, Canada K0B 1L0; fDepartment of Pathology, University of Miami Miller School of Medicine, Miami, FL 33136; gBraman Family Breast Cancer Institute, University of Miami Miller School of Medicine, Miami, FL 33136; hInterdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136; iSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136; and jHarvard Stem Cell Institute, Cambridge, MA 02138 Contributed by Mitzi I. Kuroda, April 6, 2017 (sent for review February 7, 2017; reviewed by Sharon Y. R. Dent and Jerry L. Workman) To investigate the mechanism that drives dramatic mistargeting of and, in the case of MYC, leads to differentiation in culture (2, 3). active chromatin in NUT midline carcinoma (NMC), we have Similarly, small-molecule BET inhibitors such as JQ1, which identified protein interactions unique to the BRD4–NUT fusion disengage BRD4–NUT from chromatin, diminish megadomain- oncoprotein compared with wild-type BRD4.